Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac

Background. A meningococcal group A conjugate vaccine, PsA-TT (MenAfriVac), developed through the Meningitis Vaccine Project and manufactured by the Serum Institute of India, Ltd, was tested in multiple clinical trials conducted mainly in Africa. The impact of age at which subjects were vaccinated o...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Infect Dis
Главные авторы: Tang, Yuxiao, Plikaytis, Brian D., Preziosi, Marie-Pierre, Borrow, Ray
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2015
Предметы:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639503/
https://ncbi.nlm.nih.gov/pubmed/26553685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ601
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы